The future of precision medicine starts here
Our mission is to develop novel microbiome-based therapeutics and companion diagnostics aimed at the prevention and treatment of chronic diseases.
See Our Science
Breaking News:
Siolta Therapeutics receives a Grand Challenges Exploration award
The Grand Challenges Exploration (GCE) program, an initiative supported by the Bill & Melinda Gates Foundation, provides grants to address global health challenges. We are honored to have received a grant (GCE Round 22) supporting the development of novel culturing and manufacturing processes for live biotherapeutic products.
Learn More
News
Siolta Collaboration with Bio-Me
Microbiome-based Prognostics for Early Identification of Allergy and Asthma
November 23, 2020
Read More
News
Siolta Therapeutics closes financing round to support clinical development of lead program
Series B – $30 Million
September 22, 2020
Read More
News
FDA grants Fast Track status to Siolta Therapeutics lead clinical program
Fast Track Designation
August 7, 2020
Read More